Search results
Results From The WOW.Com Content Network
In the United States, health insurance companies may not pay for a medical marijuana prescription as the Food and Drug Administration must approve any substance for medicinal purposes. Before this can happen, the FDA must first permit the study of the medical benefits and drawbacks of the substance, which it has not done since it was placed on ...
Right now, medical marijuana is commonly used to treat nausea, chronic pain, glaucoma and a range of other issues. But that might not be all that the drug can do. Several studies have uncovered ...
Research on the medical benefits of cannabis has been hindered by various federal regulations, including its Schedule I classification. [3] To conduct research on cannabis, approval must be obtained from the Food and Drug Administration, [4] and a license must be obtained from the Drug Enforcement Administration specific to Schedule I drugs. [5]
A dried cannabis flower. The short-term effects of cannabis are caused by many chemical compounds in the cannabis plant, including 113 [clarification needed] different cannabinoids, such as tetrahydrocannabinol, and 120 terpenes, [1] which allow its drug to have various psychological and physiological effects on the human body.
According to Business Insider, only 6% of studies on marijuana focused on the drug's benefits. But there are so many.
Marijuana impacts young people's mental development, their ability to concentrate in school, and their motivation and initiative to reach goals. And marijuana affects people of all ages: Harvard University researchers report that the risk of a heart attack is five times higher than usual in the hour after smoking marijuana.
The medical establishment had come to view Suboxone as the best hope for addicts like Patrick. Yet of the dozens of publicly funded treatment facilities throughout Kentucky, only a couple offer Suboxone, with most others driven instead by a philosophy of abstinence that condemns medical assistance as not true recovery.
The Kentucky Medical Cannabis Program — which regulates the legal cultivation, production, sale and use of medical marijuana products — is set to officially start Jan. 1, 2025.. But before ...